Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Plcoskin logo — Plcoskin is a MedTech company specializing in reconstructive...

Plcoskin

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare.

Founded 2017 Korea South Korea South 1 employees Series B Total: $900.00M Biopharma, Biotechnology +1

General Information

Company Name Plcoskin
Founded Year 2017
Location Korea South Korea South +1
Founders / Decision Makers
Team member
Employees 1
Industries Biopharma, Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when Plcoskin moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Plcoskin

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare. They have developed a scaffold that removes the need for cadaver-sourced material used in breast reconstruction surgery, making procedures safer and cheaper. Plcoskin’s scaffolds are made with synthetic PCL, a biodegradable material that is commonly used to create surgical sutures. Unlike competitors' products that remain in the body for a lifetime, Plcoskin’s PCL scaffolds are absorbed and replaced with the recipient’s own natural tissues, minimizing the possibility of long-term side effects. As they do not contain any dangerous chemicals, they are also 50% safer than cadaver-sourced scaffolds. Costs for reconstructive breast surgery are brought down by 40% to only $3 thousand per breast. Furthermore, much less handling time is required, reducing average surgery durations from an hour and a half to only 30 minutes. The mesh design of the scaffolds mitigates the need for an additional follow-up reconstructive surgery, something that is common when using cadaver-sourced scaffolds. In addition to their medical devices, Plcoskin has also developed Youlief, a cosmeceutical product & therapeutic device pipeline that helps fund R&D for their medical devices. Available in the US, Europe, Taiwan, Singapore and Japan, this diversification strategy supports the company’s financial health and stability. Founded in 2017 in South Korea, Plcoskin secured a Series B investment on 31 August 2023. Key investors in this round include SJ Investment Partners, WE Ventures, Tony Investment, HG Initiative, Stick Ventures, and Helio Investment. These investments position Plcoskin to continue its innovation and expansion within the Biopharma, Biotechnology, and Health Care industries.

Taxonomy: MedTech, reconstructive plastic surgery, regenerative skincare, PCL scaffold, biodegradable material, surgical innovation, cosmeceuticals, therapeutic devices, surgical technology, biomedical engineering, innovative skincare, medical innovation, surgical safety

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 6
Investor Investor Investor
•••• •••• 		31 Aug 2023
Series A •••••• 2
Investor
•••• •••• 		18 Jan 2021
Seed Round •••••• 1 •••• •••• 01 Oct 2020
Seed Round •••••• 1 •••• •••• 30 Sep 2019
Seed Round •••••• - 30 Aug 2019

Plcoskin Alternatives & Competitors

Plcoskin vs
AROSurgical Instruments Corporation
AROSurgical Instruments Corporation United States

AROSmicro Clamps ~ AROSuture ~ Precision Handheld Instruments

2-10 employees
Design, Manufacturing
Plcoskin vs
BLOOCELL®
BLOOCELL® Turkey

the language of technology

Seed
8 employees
Plcoskin vs
Val Plastic Surgery
Val Plastic Surgery United States

Dr. Sybile Val is a fully trained plastic and reconstructive surgeon dedicated to providing her pati...

2 employees

FAQ About Plcoskin

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare.
Plcoskin was founded in 2017.
Plcoskin is headquartered in Korea South.
Plcoskin operates in the following industries: Biopharma, Biotechnology, Health Care.
Plcoskin has approximately 1 employees.
Plcoskin has completed 5 funding rounds, raising a total of $900.00M. The latest funding stage is Series B.
Top alternatives and competitors to Plcoskin include AROSurgical Instruments Corporation, BLOOCELL®, Val Plastic Surgery, Osteopore (OSX.AX), Bolder Surgical . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Plcoskin and AROSurgical Instruments Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Plcoskin and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes